Simultaneous Initiation of Dolutegravir-Based Antiretroviral Treatment and Once-Weekly Rifapentine and Isoniazid (3HP) for Tuberculosis Prevention in Antiretroviral-Naïve People with HIV: A Phase 1/2 Trial
crossref(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined